The phagocyte NADPH-dependent oxidase generates superoxide by reducing molecular oxygen through a transmembrane heterodimer known as flavocytochrome b 558 (flavocytochrome b). We investigated the biosynthesis of flavocytochrome b subunits gp91 phox and p22 phox to elucidate features of flavocytochrome b processing in myeloid cells. Although the gp91 phox precursor, gp65, was processed to gp91
The phagocyte NADPH-dependent oxidase generates superoxide by reducing molecular oxygen through a transmembrane heterodimer known as flavocytochrome b 558 (flavocytochrome b). We investigated the biosynthesis of flavocytochrome b subunits gp91 phox and p22 phox to elucidate features of flavocytochrome b processing in myeloid cells. Although the gp91 phox precursor, gp65, was processed to gp91
phox within 4 -8 h of chase, unassembled gp65 and p22 phox monomers were degraded by the cytosolic proteasome. gp65 associated with p22 phox post-translationally, within 1-4 h of chase, but prior to its modification in the Golgi complex. Moreover, p22 phox coprecipitated with unglycosylated gp91 phox primary translation product made in the presence of tunicamycin, suggesting that heterodimer formation does not require glycosylation. Blocking heme synthesis with succinyl acetone completely inhibited heterodimer formation, although biogenesis of gp65 and p22 phox was unaffected. In succinyl acetone-treated cells, p22 phox and gp65 were degraded completely by 8 h of chase, a process mediated by the cytosolic proteasome. Taken together, these data suggest that the formation of the gp65-p22 phox heterodimer is relatively inefficient and that acquisition of heme by gp65 precedes and is required for its association with p22 phox , a process that requires neither the addition of N-linked oligosaccharides nor modification in the Golgi complex.
The oxygen-dependent microbicidal activity of phagocytes depends on the production of superoxide (O 2 . ) by the NADPHdependent oxidase. The oxidase is a multimeric enzyme complex containing both cytosolic and membrane-bound proteins (reviewed in Refs. [1] [2] [3] . During phagocyte activation, p47
phox (4 -6), p67 phox (4, 7), p40 phox (8) , and a low molecular mass GTPase (Rac2) (9, 10) translocate from the cytosol and associate with the membrane-bound component flavocytochrome b 558 (referred to here as flavocytochrome b) (11) (12) (13) . Although their functions are not precisely defined, the cytosolic components must interact with flavocytochrome b to form a functional oxidase (11, 14) . Flavocytochrome b alone contains all of the redox components necessary for the transfer of electrons from NADPH to oxygen (15, 16) . It is a transmembrane heterodimer, consisting of a 91-kDa large subunit (gp91 phox ) and a 22-kDa small subunit (p22 phox ), each the product of a unique gene (17) (18) (19) . Recent evidence suggests that gp91 phox contains two hemes with very low midpoint redox potentials that presumably mediate the transfer of electrons from NADPH to oxygen (20, 21) . In addition, gp91 phox has three putative sites for Nlinked glycosylation that are extensively modified in the Golgi apparatus (18, (22) (23) (24) ; however, a functional role for the glycosylation has not been demonstrated. There are also conserved regions within gp91
phox containing homology to nucleotide-binding domains found in other flavoproteins such as ferredoxin:NADP ϩ reductase (25, 26) . Therefore, gp91 phox likely binds both flavin adenine dinucleotide and NADPH (25, 27, 28) , although recent evidence suggests that p67 phox also may participate in the binding of NADPH (29, 30) .
Porter et al. (31, 32) first proposed the existence of a putative gp91 phox precursor when they identified a 65-kDa polypeptide in Epstein-Barr virus-transformed B-lymphocytes derived from individuals deficient in p22
phox . This 65-kDa protein was immunoreactive with antibody specific for gp91 phox and could be readily digested with ␤-endoglycosaminidase H or peptide Nglycanase F to yield a protein of ϳ55-58 kDa (31). Introduction of a p22 phox transgene into these cells resulted in the generation of fully processed flavocytochrome b containing both gp91 phox and p22 phox (31 clinically by recurrent bacterial and fungal infections (37) . Both X-linked CGD, reflecting a deficiency of gp91 phox , and autosomal deficiency of p22 phox are characterized by the absence of the gp91-p22 phox heterodimer (31, 38 -40) . These phenotypic characteristics suggest that neither gp91 phox nor p22 phox is independently stable and that they are not targeted to the plasma membrane or specific granules individually, although direct evidence supporting the former interpretation is lacking (31, 32, 38 -40) . There are several examples of multimeric proteins whose proper subcellular targeting requires normal synthesis of each component subunit. Abnormal synthesis of CD18, the common ␤-chain subunit shared by all members of the ␤ 2 -integrin family, underlies leukocyte adhesion deficiency-1 (41, 42) . Leukocytes from individuals with leukocyte adhesion deficiency-1 lack surface expression of LFA-1, Mac-1, and p150/95 because, in the absence of normal ␤-chain synthesis, nascent ␣-chains cannot associate into heterodimers and thus are not targeted to the plasma membrane in a normal fashion. For both X-linked and p22
phox -deficient CGD, the majority of patients with missense mutations or small in-frame deletions or insertions lack detectable flavocytochrome b, suggesting that these mutations may interfere with protein folding and/or heterodimer formation. By analogy with leukocyte adhesion deficiency-1, one might predict that in individuals with X-linked CGD or autosomal recessive mutations of p22 phox , the absence of normal synthesis of either subunit would undermine surface expression of the functional heterodimer at the plasma membrane.
As an initial step toward understanding the biogenesis of flavocytochrome b, we examined the synthesis of gp91 phox and p22 phox and the role of glycosylation in the maturation and processing of flavocytochrome b in a human promyelocytic leukemia cell line. Furthermore, we present data that demonstrate that the acquisition of heme by gp65 is a prerequisite for the formation of the gp65-p22 phox heterodimer early in flavocytochrome b biosynthesis.
EXPERIMENTAL PROCEDURES

Materials-[
35 S]Methionine/cysteine (7.18 mCi/0.5 ml; specific activity, 1000 Ci/mmol; Promix), protein A-Sepharose CL-4B, and GammaBind protein G-Sepharose were obtained from Amersham Pharmacia Biotech. Heat-killed, Formalin-fixed, protein A-bearing Staphylococcus aureus (Pansorbin) cells were purchased from Calbiochem. Fetal bovine serum and RPMI 1640 medium (ϮL-methionine) were purchased from Life Technologies, Inc. Peptide N-glycanase F was obtained from Roche Molecular Biochemicals. The hybridoma cell line expressing mAb 44aacb, specific for CD11b, was obtained from American Type Culture Collection (HB-249), and mAb 44aacb was purified by Zulfiqar A. Malik (Department of Medicine, University of Iowa, Iowa City, IA). All other reagents were purchased from Sigma unless otherwise specified.
Metabolic Labeling and Immunoprecipitation of Flavocytochrome b-A previously described human promyelocytic leukemia cell line with a deleted CYBB gene (X-CGD PLB) (43) and X-CGD PLB cells constitutively expressing a gp91 phox transgene (gp91-PLB) (43) were used for biosynthetic labeling experiments. Metabolic labeling in each cell line was performed using a previously described protocol (44) . Where indicated, proteasome inhibitors (from 50 mM stock solutions in Me 2 SO) were added during the incubation in methionine-free medium and were present for the duration of the chase period. For experiments in which it was necessary to inhibit glycosylation, cells were incubated for 1 h in the presence of 5 g/ml tunicamycin or for 2 h with 5 g/ml brefeldin A (BFA) prior to metabolic labeling and also for the indicated chase period. To block heme synthesis, cells were cultured for 16 -24 h with 10 g/ml succinyl acetone (SA), which was present for the duration of the experiment. For experiments examining translation rates, cells were pulse-labeled for 1-15 min with [ 35 S]methionine, followed by the addition of 100 g/ml cycloheximide, and subsequently were diluted into ice-cold methionine-free medium containing 100 g/ml cycloheximide. At the end of the labeling or chase period, cells were centrifuged at 350 ϫ g for 6 min at 4°C, and the cell pellet was solubilized in RIPA buffer (10 mM sodium phosphate, pH 7.2, containing 1% Triton X-100, 1% Nonidet P-40, 1% sodium deoxycholate, 0.05% SDS, 150 mM NaCl, 1 mM EDTA, 20 mM NaF, 0.4 units/ml aprotinin, and 2 mM phenylmethylsulfonyl fluoride) for at least 30 min on ice or overnight. Following the addition of 500 l of RIPA buffer to each lysate, samples were precleared with Pansorbin-protein A as described previously (44) . 10 -12 g of mAb specific for gp91 phox , mAb 54.1 (␣gp91 phox ), or for p22 phox , mAb 44.1 (␣p22 phox ) (45, 46) , was added to each lysate and tumbled at 4°C for at least 4 h or overnight. ␣gp91 phox immune complexes were incubated further with 12 g of goat antibody specific for mouse IgG (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) for 60 min. All immune complexes were captured for 40 -60 min using 40 l of protein A-Sepharose CL-4B according to the manufacturer's instructions. Immune complexes were washed three to four times in RIPA buffer and then resolved by 5-20% SDS-PAGE and visualized by autoradiography (see below). Where indicated, samples were digested with peptide N-glycanase F and then subjected to SDS-PAGE (44) . For detection of gp91 phox and p22 phox by immunoblotting, immune complexes were detected using a combination of ␣gp91 phox and ␣p22 phox . Immunoblots were developed using an enhanced chemiluminescence detection system (SuperSignal substrate, Pierce) according to the manufacturer's instructions.
SDS-PAGE and Autoradiography-Proteins were separated by 5-20% SDS-PAGE, and gels were fixed, dried, and then exposed to Kodak X-Omat film for 16 -72 
Methionine gels were quantitated using a PhosphorImager SF (Molecular Dynamics, Inc., Sunnyvale, CA) or by densitometry using an IS-1000 digital imaging system (Alpha Innotech, San Leandro, CA). To detect radiolabeled p22
phox following immunoprecipitation with ␣p22 phox or p22 phox coprecipitating with gp65/gp91 phox , it was necessary to expose autoradiograms 2-4 days longer than was necessary for gp65/gp91 phox . All comparative analyses were performed using the same autoradiogram at a given exposure time, i.e. a comparison of X with Y was done from a single autoradiogram illustrating X and Y.
RESULTS AND DISCUSSION
Biosynthetic Labeling and Immunoprecipitation of gp91 phox and p22
phox -Monoclonal antibodies specific for gp91 phox and p22 phox (␣gp91 phox and ␣p22 phox , respectively) were used to immunoprecipitate flavocytochrome b and/or individual flavocytochrome b subunits. We determined empirically that solubilization of gp91-PLB cells in RIPA buffer yielded the best recovery of flavocytochrome b following immunoprecipitation. ␣gp91 phox precipitated gp91 phox and its high-mannose precursor, gp65, in addition to coprecipitating p22 phox ( Fig. 1 ). ␣p22 phox precipitated p22 phox and coprecipitated gp91 phox ; however, coprecipitation of gp65 was not detected (Fig. 1 significant molar excess in comparison with the rapidly processed gp65-p22 phox heterodimer, then coprecipitation of gp65 might be difficult to detect.
To assess the potential binding of gp65 and p22 phox , we evaluated the processing of gp91 phox and p22 phox during the formation of flavocytochrome b in biosynthetically labeled gp91-PLB cells. Following a 1-h pulse with [ 35 S]methionine, a 65-kDa protein, gp65, was precipitated from solubilized gp91-PLB cells using ␣gp91 phox , but not from X-CGD PLB lysates ( Fig. 2A , compare left and right panels, 0 h of chase). These results demonstrate that gp65 is the precursor polypeptide to gp91 phox and complement our previous studies demonstrating that gp91
phox is synthesized as a 65-kDa precursor in the ER (34) . Cells were chased with unlabeled methionine to follow the processing of gp65 to mature gp91 phox and to elucidate the time point during synthesis at which it associated with p22 phox . Although the signal intensity for radiolabeled gp91 phox was significantly less in comparison with gp65, we found that gp91 phox was detectable by as early as 2 h of chase; however, complete maturation of gp65 to gp91 phox routinely required 4 -8 h of chase (Figs. 2A, 3-5, and 7) .
During gp91 phox synthesis, there was loss of signal intensity over time during maturation of gp65 to form gp91 phox , i.e. the sum of signals from gp65 and gp91 phox appeared to decrease over time (Fig. 2, A and B) . Using densitometry, we estimated that only 53.3 Ϯ 4.6% of the gp65 synthesized was processed to gp91 phox (Fig. 2B, compare closed and open triangles) . However, we were concerned that this loss may be more apparent than real, as the diffuse nature of gp91 phox migration during SDS-PAGE might appear as an apparent overall loss of signal intensity on the corresponding autoradiogram when compared with tightly resolved gp65. To address this concern, we compared the signal intensities of gp65 and gp91 phox after deglycosylation using peptide N-glycanase F following metabolic labeling and immunoprecipitation with ␣gp91 phox (Fig. 2B , inset). Digested gp65 and gp91 phox migrated as a single protein species at ϳ58 kDa on SDS-PAGE (Fig. 2B, inset) . Densitometric analysis of the deglycosylated protein demonstrated that only 28.5 Ϯ 10.3% of the synthesized CYBB gene product was present at 8 h of chase when compared with that at 0 h of chase (Fig. 2B) . Since the 58-kDa core protein represents the sum of precipitated gp65 and gp91 phox , and little or no gp65 was precipitated from gp91-PLB cell lysates at 8 h of chase ( Fig. 2A) , these data indicate that a significant portion of gp65 was degraded rather than processed to gp91 phox . A similar reduction in the recovery of labeled p22
phox was observed over the chase 
phox (middle panels) were also exposed longer than those illustrating precipitation of p22 period following precipitation with ␣p22 phox (Fig. 2, A and C) . Peak recovery of newly synthesized p22 phox was observed immediately after the 1-h pulse and decreased by 54.9 Ϯ 12.1% by 8 h of chase (Fig. 2C ). When compared with that produced in gp91-PLB cells, p22
phox from X-CGD PLB cells was less stable. Only 30.0 Ϯ 4.5% of the newly synthesized p22
phox remained in X-CGD PLB cells by 8 h of chase compared with 45.2 Ϯ 12.1% in gp91-PLB cells (Fig. 2C) . It is likely that all of the newly synthesized p22
phox in X-CGD PLB cells was eventually degraded since we detected very little by immunoblotting the ␣p22 phox immunoprecipitates (Fig. 1) . The increased instability of p22 phox in X-CGD PLB cells when compared with that in gp91-PLB cells likely reflects its inability to form the gp91-p22 phox heterodimer. Porter et al. (31) reported the complementary phenomenon, namely that gp91 phox was unstable and largely degraded in p22
phox -deficient Epstein-Barr virus-transformed lymphocytes.
It has been reported that many properly folded proteins synthesized in the ER are degraded following retrograde translocation to the cytosolic proteasome (Refs. 47-49 and reviewed in Refs. 50 and 51). To determine if gp65 underwent proteasomal degradation, we tested the impact of two known peptide aldehyde inhibitors of the 26 S (Fig. 3) . ALLM is 10-fold less potent at inhibiting proteasome function than is ALLN and was used as a negative control at low concentrations. ALLN at 50 M inhibited significantly the degradation of gp65 and p22 phox (Fig. 3) ; levels of gp65 and p22 phox were increased 3.1 Ϯ 0.9-and 3.9 Ϯ 0.3-fold, respectively, by treatment with 50 M ALLN. By contrast, a similar concentration of ALLM was ineffective at blocking proteolysis, and only at 500 M ALLM was degradation comparably inhibited (at 50 M ALLM, the amount of gp65 increased only 0.46 Ϯ 0.4-fold above that in untreated cells, and no increase in p22 phox was observed) (Fig. 3) . Although, the reduction of proteolysis was not enough to maintain the level of gp65 synthesized initially (by 4 h of chase, gp65 was reduced to 10.9 Ϯ 0.1% of that at 0 h of chase in these experiments; this level was increased to 30.9 Ϯ 8.8% by treatment with 50 M ALLN), these results suggest that a loss of gp65 and p22 phox during processing was mediated in part by degradation in the cytosolic proteasome.
Formation of the gp65-p22 phox Heterodimer-A small, but detectable fraction of p22 phox coprecipitated with gp65 after the 1-h pulse (Figs. 2A, 6 , and 7, 0 h of chase). By 1 h of chase, coprecipitation of p22 phox with gp65 was readily detected, even though gp65 was not yet modified to gp91
phox . Coprecipitation of p22
phox with gp65/gp91 phox increased concomitantly with the chase interval and also paralleled the processing of gp65 to gp91 phox ( Fig. 2A) . The fact that less p22 phox had coprecipitated after the 1-h pulse (at 0 h of chase) compared with that at later chase times was not due to a lack of p22 phox since peak recovery of labeled p22
phox by precipitation with ␣p22 phox occurred immediately following the 1-h pulse (Fig. 2 , A (compare middle and lower panels, 0 h of chase) and C). More radiolabeled p22 phox coprecipitated with gp65 over the chase period, suggesting that the binding of p22 phox with gp65 occurred after the synthesis of each subunit was complete.
Although the preceding data argue against the co-translational association of gp65 and p22
phox , we performed immunodepletion experiments to assess more precisely whether the gp65-p22 phox heterodimer formed during translation or posttranslationally (Fig. 4) . Three sequential precipitations using either ␣p22 phox or ␣gp91 phox depleted gp91-PLB cell lysates of p22 phox or gp65/gp91 phox , respectively (Fig. 4) . However, depletion of p22 phox or gp65 removed little of the complementary subunit at 0 h of chase, i.e. depleting lysates of p22 phox did not decrease the amount of gp65 recovered at 0 h of chase (Fig. 4 , compare upper and lower panels, ␣gp91 phox precipitations). In contrast, nearly all of the gp91 phox was removed from lysates after sequential precipitation with ␣p22 phox at 4 h of chase (Fig.  4, compare upper and lower panels, gp91 phox from the ␣gp91 phox precipitations). Similarly, p22 phox was depleted from lysates following sequential precipitation with ␣gp91 phox at 4 h of chase (Fig. 4, compare upper and lower panels, p22 phox from the ␣p22 phox precipitations). Since three rounds of precipitation with ␣gp91 phox and ␣p22 phox completely removed gp65 and p22 phox , respectively, from lysates at 0 h of chase, but removed little of the complementary subunit, i.e. p22 phox and gp65, respectively, most of the gp65 and p22 phox did not exist as a heterodimer at 0 h of chase (Fig. 4) . Moreover, the depletion of gp91 phox with ␣p22 phox and of p22 phox with ␣gp91 phox from lysates by 4 h of chase further substantiates our finding that the mature heterodimer was formed by 4 h of chase ( Fig. 2A) . It is also noteworthy that once the gp91-p22 phox heterodimer had formed, it was significantly more stable than either subunit alone, as the amount of gp91-p22 phox heterodimer immunoprecipitated at 20 h of chase was nearly identical to that at 8 h of chase (data not shown).
We were concerned that discordant rates of synthesis for either gp65 or p22 phox may have resulted in the existence of a large pool of unassembled, unlabeled monomer subunits that might potentially assemble with labeled precursors, confounding the interpretation of our coprecipitation experiments. Therefore, we evaluated the translation rates for both subunits using the method described by Horwitz et. al. (52 ϳ2.5 and 2.2 amino acids/s, respectively (data not shown). Thus, the rates of protein synthesis for the subunit polypeptides were comparable and also similar to those reported for the Cystic fibrosis transmembrane conductance regulator and other proteins (52, 53) . Since the rates of synthesis for gp65 and p22 phox did not differ significantly, the kinetics of recovered p22 phox coprecipitated with ␣gp91 phox ( Fig. 2A) closely approximated heterodimer formation.
Glycosylation and Heterodimer Formation-Because the binding of gp65 with p22
phox paralleled its transformation to gp91 phox , we reasoned that formation of the gp91-p22 phox heterodimer could be occurring in the Golgi complex. To determine if the gp65/gp91 phox -p22 phox heterodimer formed in the ER or Golgi, we cultured gp91-PLB cells in the presence of BFA, a fungal metabolite that disrupts the Golgi complex and, consequently, ER-to-Golgi protein trafficking (54) . Cells cultured with BFA did not modify high mannose-containing carbohydrates on gp65 to generate gp91 phox , and this treatment did not adversely affect synthesis of p22 phox (Fig. 5) . Moreover, p22 phox coprecipitated with gp65 using ␣gp91 phox in BFA-treated cells, demonstrating that preventing transport of subunits into the Golgi complex did not block the formation of the gp65-p22 phox complex (Fig. 5) . Since BFA treatment induces fusion of the Golgi complex with the ER, we cannot exclude the possibility that certain Golgi enzymes might have been functional in the ER during BFA treatment and that if heterodimer assembly occurred in the Golgi, it might not be blocked by BFA treatment. However, these data suggest that carbohydrate modification of gp65 in the Golgi complex was not required for the binding of p22 phox and that heterodimer formation likely preceded the modification of gp65 in the trans-Golgi complex to form gp91
phox , consistent with the data in Fig. 2A . Although the BFA experiments indicated that complex carbohydrates on gp91 phox were unnecessary for p22 phox binding, they did not address a potential requirement for glycosylation in heterodimer formation. To determine whether glycosylation was required for the binding of p22 phox , we inhibited N-linked glycosylation of gp65 in gp91-PLB cells using tunicamycin (Fig.  6) . Tunicamycin inhibits the synthesis of high mannose-containing carbohydrates on dolichol phosphate, completely blocking N-linked glycosylation. gp91-PLB cells grown in the presence of tunicamycin synthesized an immunoreactive protein of 58 kDa (Fig. 6) , the approximate size of the gp91 phox core protein shown in Fig. 2B . In the presence of tunicamycin, this gp91 phox core protein was not processed to gp91 phox during the 8-h chase with unlabeled methionine (Fig. 6) . Furthermore, p22
phox coprecipitated with the 58-kDa gp91 phox -related core protein in cells cultured in the presence of tunicamycin, as in the cells treated with BFA (Fig. 6 ). Although protein synthesis was diminished overall, resulting in reduced amounts of either p22 phox or 58-kDa core protein, the ratios of p22 phox to gp91 phox precursor in tunicamycin-treated and untreated cells were similar: 6.6 Ϯ 1.7 for those treated with tunicamycin and 9.5 Ϯ 2.3 for control cells. These results, in combination with the data presented above, demonstrate that the formation of flavocytochrome b heterodimers required neither N-linked glycosylation nor transit into the Golgi complex. Heme Acquisition and Heterodimer Formation-The binding of heme by flavocytochrome b has been implicated in the stability of gp91 phox and p22 phox (33, 34) . To determine whether the binding of heme was necessary for the maturation of flavocytochrome b, gp91-PLB cells were cultured in the presence of SA, an inhibitor of 5-aminolevulinic dehydratase and thus heme synthesis (Fig. 7A) . Precipitations of gp65 using ␣gp91 phox , of p22 phox using ␣p22 phox , and of CD11b with mAb 44aacb were similar in untreated or SA-treated cells immediately after the pulse with [ 35 S]methionine (levels of gp65 and p22 phox in SA-treated cells were 99.5 Ϯ 3.5 and 105.4 Ϯ 8.1%, respectively, of those in untreated cells) (Fig. 7A) . Therefore, the initial synthesis of gp65, p22 phox , and a non-heme-containing transmembrane protein (CD11b) was unaffected by the availability of heme (Fig. 7A) . By contrast, SA treatment completely inhibited the coprecipitation of p22 phox with gp65 or of gp91 phox using ␣gp91 phox (Fig. 7, A and B) . These data demonstrate conclusively that the binding of p22 phox with gp65 is dependent on the acquisition of heme. Although translation of p22 phox and gp65 was unaffected by SA treatment, gp65 was not processed to gp91 phox in SA-treated cells, and both p22 phox and gp65 were completely degraded by 8 h of chase (Fig. 7, A  and B) . This finding supports our previous studies that suggest that the relative stabilities of gp91 phox and p22 phox are governed, in part, by the availability of heme (33, 34) . There was relatively more gp65 by 4 h of chase in SA-treated cells compared with that in untreated cells (Fig. 7B) ; only 24.6 Ϯ 6.3% of the labeled gp65 remained in untreated cells by 4 h of chase compared with 57.1 Ϯ 4.6% in SA-treated cells (Fig. 7B) . It is tempting to speculate that the accumulated species in SAtreated cells, presumably apo-gp65, represents that fraction of gp65 molecules that would have been processed to gp91 phox in a heme-enriched environment. Degradation of gp65 in SAtreated cells could be partially inhibited by the proteasome inhibitor ALLN (Fig. 7B) 0 h chase was still present by 8 h chase in cells treated with both SA and 50 M ALLN compared with only 17.5 Ϯ 2.1% in SA-treated cells and 6.6 Ϯ 2.7% in untreated cells (Fig. 7A) . Since gp65 degradation could be only partially blocked by ALLN, degradation may not be mediated exclusively in the proteasome. In combination, the data presented in Figs. 2A and 7A suggest that gp65 likely acquired heme within 1-2 h of synthesis. The acquisition of heme by gp65 may be the key event that dictates its eventual fate, i.e. the fraction of gp65 molecules that receive heme are spared degradation by the cytosolic proteasome. Further experimentation will be necessary to test this hypothesis and to determine specific structural requirements conferred by heme in the binding of p22
phox . Conclusions-Biogenesis of multisubunit proteins in the ER has only recently been investigated, and much of our understanding of their synthesis is derived from studies of T-cell receptor-CD3 complexes or major histocompatibility class II molecules (55) (56) (57) (58) (59) (60) (61) (62) (63) . However, many features of multisubunit protein synthesis are undefined, and the mechanism for the acquisition of heme by many heme-associated proteins is also incompletely understood. Therefore, understanding the biosynthesis of flavocytochrome b will likely elucidate general characteristics of the biosynthesis of multisubunit, transmembrane, and/or heme-containing proteins. In addition, defining the determinants of flavocytochrome b biosynthesis, assembly, and intracellular targeting will advance the understanding of the pathogenesis of X-linked or p22
phox -deficient CGD at the level of protein synthesis. In our current studies, we have elucidated several basic features of flavocytochrome b biosynthesis.
Based on our coprecipitation data, initial gp65-p22 phox complexes were formed within the 60-min pulse with [
35 S]methionine, although optimal recovery of both subunits by coprecipitation was achieved by 4 h of chase (Figs. 2, 4, and 5) . Given the 4-h interval between detection of initial complexes and their optimal recovery, it was difficult to determine whether all complexes formed at a specific time or whether heterodimer formation was asynchronous. The synthesis and processing of flavocytochrome b were also surprisingly inefficient, as significant fractions of newly synthesized gp65 and p22 phox were degraded by the cytosolic proteasome (Figs. 2 (A-C) and 3) . Our current data suggest that gp65-p22 phox complexes were significantly more stable than either uncomplexed subunit. The inherent stability of multisubunit proteins relative to that of constituent polypeptides is characteristic of the T-cell receptor-CD3 complex, major histocompatibility class II molecules, and ␤ 2 -integrins as well (55, 59, 62, 63) . For example, Kearse et al. (56) found that the initial association of T-cell receptor-␣ with the CD3 ␦⑀-chains prevents T-cell receptor-␣ from ER degradation in maturing thymocytes. The association of Ii subunits with major histocompatibility class II ␣-and ␤-chain molecules confers stability to the formed complex (59) . Although the formation of subunit complexes in the ER may rescue individual subunits from destruction, our understanding of cellular mechanisms that recognize unbound proteins from those in a macromolecular complex is limited. The elucidation of such a mechanism will be directly relevant to understanding the biochemical phenotype of CGD since it is likely that in many cases involving missense or in-frame deletion/insertions, the absence of either gp91 phox or p22 phox in individuals with CGD results from an inability of gp65/gp91 phox to associate with p22
phox . associated with gp65 in BFA-treated cells, our data suggest that the binding of gp65 with p22 phox occurred before the complex entered the Golgi apparatus (Fig. 5) . Thus, movement of gp65-p22 phox into the Golgi complex required at least 4 h. A role for the extensive glycosylation of gp91 phox has not been reported, although N-glycans have been shown to serve as sorting signals in the trans-Golgi network (64) . Moreover, glycosylation can play a role in protein folding and stability, as observed with GD3 synthase or human thyroperoxidase (65, 66) . However, we observed that glycosylation was not required for the formation of the flavocytochrome b heterodimer since the binding of p22 phox with unglycosylated gp65 was unaffected (Fig. 6 ). We also found that the acquisition of heme by gp65 preceded and was necessary for the binding of p22
phox . In the absence of heme, both gp65 and p22
phox were degraded by 8 h of chase (Fig. 7) . Our findings on the requirement for heme in heterodimer formation are compatible with the observation that individuals containing mutations in predicted heme-binding histidines of gp91 phox develop CGD with little or no detectable flavocytochrome b (67, 68) . Currently, there are conflicting views about the distribution of heme in mature flavocytochrome b (20, 69, 70) . In contrast to earlier studies by Jesaitis and co-workers (69) that demonstrated that gp91 phox and p22 phox each bound heme, Dinauer and co-workers (20) observed that p22
phox alone did not produce a heme spectrum and thus concluded that gp91 phox contains both hemes. Since we found that heme was required for the binding of p22 phox with gp65, it is possible that the acquisition of both hemes by gp91 phox provides the structural constraint necessary for the subsequent association with p22 phox . Alternatively, if one heme bound exclusively to gp91 phox , whereas the other heme was shared between gp91 phox and p22 phox , as suggested by Jesaitis and co-workers (70), then one would anticipate that blocking the acquisition of heme would directly prevent heterodimer formation. Thus, our studies do not resolve the dispute, as demonstration of the requirement for heme in heterodimer formation is compatible with either scenario.
These studies outline the biosynthesis of normal flavocytochrome b and demonstrate the importance of heme incorporation in its assembly and maturation. Additional studies will be necessary to identify specific structural determinants of heterodimer formation, particularly as they relate to heme incorporation into the nascent polypeptide. Given that the precise location of the heme in flavocytochrome b is the subject of considerable debate, the impact of specific mutants on flavocytochrome b biosynthesis may identify novel and important features of heterodimer formation and targeting of the functional flavocytochrome b to the plasma membrane and/or specific granules. Conclusions derived from such studies will advance the understanding not only of the functional consequences of phox was precipitated using ␣gp91 phox (second row of panels); p22 phox was precipitated using ␣gp91 phox (fourth row of panels), and CD11b was precipitated using mAb 44aacb (first row of panels). p22 phox coprecipitating with gp65/gp91 phox is shown in the third row of panels. Results are representative of three to five separate experiments. B, alternatively, cells cultured with SA were treated with the proteasome inhibitor ALLN as described under "Experimental Procedures." Results are from a representative experiment performed twice. IP, immunoprecipitation. missense mutations in gp91 phox and p22 phox underlying many forms of CGD specifically, but also of the biosynthesis of hemecontaining membrane proteins in general.
